文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肝细胞癌的放射治疗方法。

Approach to radiation therapy in hepatocellular carcinoma.

机构信息

Key Laboratory of Radiobiology (Ministry of Health), School of Public Health, Jilin University, Changchun, China.

出版信息

Cancer Treat Rev. 2010 Apr;36(2):157-63. doi: 10.1016/j.ctrv.2009.11.008. Epub 2009 Dec 23.


DOI:10.1016/j.ctrv.2009.11.008
PMID:20031332
Abstract

Hepatocellular carcinoma (HCC), the 5th most common cancer and the third most common cause of cancer-related death in the world with an estimated incidence of approximately 1 million new cases annually, has becoming a major global health problem in the world. A variety of treatment modalities, including resection, liver transplantation, transarterial chemoembolization (TACE), local ablative therapy and radiation therapy (RT) have been reported. Although partial hepatectomy and liver transplantation may offer the best chance of cure, only 15% of the patients have the chance to be treated by surgery when diagnosed. The effectiveness of systemic chemotherapy for HCC has been minimal, and local ablative therapy may offer comparable survival in patients with small HCC and preserve liver function. Recently, with developments in radiotherapy techniques, radiotherapy has been shown to play potential roles in a wide spectrum of HCC and to become more important so that it is necessary to evaluate the effect of radiotherapy in treatment of HCC. This paper is aiming mainly at the current radiation therapy strategies and their current advances, the optimal radiation therapy strategies will complement the current treatments and improve the treatment efficiency.

摘要

肝细胞癌(HCC)是全球第 5 大常见癌症,也是第 3 大癌症相关死亡原因,全球每年估计有近 100 万例新发病例,已成为全球主要的健康问题。目前已有多种治疗方法,包括手术切除、肝移植、经动脉化疗栓塞(TACE)、局部消融治疗和放射治疗(RT)等。尽管部分肝切除术和肝移植可能提供最好的治愈机会,但只有 15%的患者在确诊时可以接受手术治疗。HCC 的全身化疗效果甚微,而局部消融治疗可能为小 HCC 患者提供相似的生存机会并保留肝功能。最近,随着放射治疗技术的发展,放射治疗已被证明在广泛的 HCC 中有潜在作用,并变得更加重要,因此有必要评估放疗在 HCC 治疗中的作用。本文主要针对目前的放射治疗策略及其进展,最佳的放射治疗策略将补充现有的治疗方法,提高治疗效率。

相似文献

[1]
Approach to radiation therapy in hepatocellular carcinoma.

Cancer Treat Rev. 2009-12-23

[2]
Radiation therapy for hepatocellular carcinoma: from palliation to cure.

Cancer. 2006-4-15

[3]
Hepatocellular carcinoma: current management and recent advances.

Hepatobiliary Pancreat Dis Int. 2008-6

[4]
Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.

Am J Clin Oncol. 2003-8

[5]
The evolving role of radiation therapy in hepatocellular carcinoma.

Cancer Radiother. 2008-3

[6]
[Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].

Ai Zheng. 2004-7

[7]
Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.

J Gastroenterol Hepatol. 2009-5

[8]
Conformal and stereotactic radiotherapy in hepatocellular carcinoma.

Ann Ital Chir. 2008

[9]
A case of hepatocellular carcinoma initially treated by carbon ions, followed by protons for marginal recurrence with portal thrombus.

Radiat Med. 2005-11

[10]
Efficacy of radiotherapy for PV and IVC tumor thrombosis in unresectable HCC.

Hepatogastroenterology. 2007-9

引用本文的文献

[1]
Deciphering cGAS-STING signaling: implications for tumor immunity and hepatocellular carcinoma.

Naunyn Schmiedebergs Arch Pharmacol. 2025-5-7

[2]
TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma.

Oncogene. 2024-2

[3]
TRIM22 induces cellular senescence by targeting PHLPP2 in hepatocellular carcinoma.

Cell Death Dis. 2024-1-10

[4]
Noninvasive morpho-molecular imaging reveals early therapy-induced senescence in human cancer cells.

Sci Adv. 2023-9-15

[5]
External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis.

Clin Exp Med. 2023-9

[6]
SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.

Cell Death Differ. 2023-1

[7]
PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination.

Theranostics. 2020

[8]
The Therapeutic Potential of Adipose Tissue-Derived Mesenchymal Stem Cells to Enhance Radiotherapy Effects on Hepatocellular Carcinoma.

Front Cell Dev Biol. 2019-11-12

[9]
Toll-like receptor 4 and its associated proteins as prognostic factors for HCC treated by post-radiotherapy surgery.

Oncol Lett. 2018-6

[10]
Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review.

J Clin Transl Hepatol. 2018-3-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索